Insights

Gathering insights about TheracosBio…

Similar companies to TheracosBio

TheracosBio Tech Stack

TheracosBio uses 8 technology products and services including Site Kit, MySQL, Google Fonts API, and more. Explore TheracosBio's tech stack below.

Site Kit
Analytics
MySQL
Database
Google Fonts API
Font Scripts
jQuery
Javascript Libraries
Elementor
Page Builders
Google Analytics
Web Analytics
Adobe Fonts
Web Fonts
Endurance Page Cache
Web Platform Extensions

Media & News

Wellgistics Health, Inc. partners with TheracosBio.
Wellgistics Health (NASDAQ:WGRX) has announced a strategic partnership with TheracosBio to expand nationwide access to Brenzavvy(R), an FDA-approved diabetes therapy, through over 6,500 pharmacies.
Sep 30, 2025 | www.stocktitan.net
TheracosBio partners with Hcroyalty.
TheracosBio announces Royalty financing agreement with HealthCare Royalty.
Aug 21, 2023 | www.businesswire.com
TheracosBio launched Brenzavvy on Jul 13th '23.
Last month, TheracosBio announced the commercial launch of Brenzavvy™ (bexagliflozin), its FDA-approved SGLT2 inhibitor.
Aug 21, 2023 | www.businesswire.com
TheracosBio hires Brian Connelly as President and Chief Executive Officer.
TheracosBio appoints Brian Connelly as Chief Executive Officer.
Jul 31, 2023 | tpmg.pro
TheracosBio hires Jim Greenwood as Chief Financial Officer.
TheracosBio Announces the Appointments of Jim Greenwood to Board of Directors and Jeff McGroarty as Chief Financial Officer TheracosBio announced the appointment of former US Congressman Jim Greenwood to the Board of Directors of its parent company and Jeff McGroarty, MBA, as its Chief Financial Officer.
Mar 14, 2023 | www.healthitanswers.net

TheracosBio's Email Address Formats

TheracosBio uses at least 2 format(s):

TheracosBio Email Formats	Example	Percentage
FLast@theracos.com	JDoe@theracos.com	67%
First@theracos.com	John@theracos.com	33%

Frequently Asked Questions

Where is TheracosBio's headquarters located?

TheracosBio's main headquarters is located at 945 Concord St, Framingham, Massachusetts 01701, US. The company has employees across 1 continents, including North America.

What is TheracosBio's official website and social media links?

TheracosBio's official website is theracosbio.com and has social profiles on LinkedIn.

What is TheracosBio's NAICS code?

TheracosBio's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does TheracosBio have currently?

As of October 2025, TheracosBio has approximately 9 employees across 1 continents, including North America. Key team members include Chief Financial Officer: J. M.Director Of Quality Assurance: R. B.Senior Director Of Strategic Accounts: J. M.. Explore TheracosBio's employee directory with LeadIQ.

What industry does TheracosBio belong to?

TheracosBio operates in the Pharmaceutical Manufacturing industry.

What technology does TheracosBio use?

TheracosBio's tech stack includes Site KitMySQLGoogle Fonts APIjQueryElementorGoogle AnalyticsAdobe FontsEndurance Page Cache.

What is TheracosBio's email format?

TheracosBio's email format typically follows the pattern of FLast@theracos.com. Find more TheracosBio email formats with LeadIQ.

When was TheracosBio founded?

TheracosBio was founded in 2000.

TheracosBio

Q: What is TheracosBio's official website and social media links?

TheracosBio's official website is theracosbio.com. TheracosBio has social profiles on LinkedIn.

Q: How many employees does TheracosBio have currently?

TheracosBio has approximately 9 employees.

Q: What technology does TheracosBio use?

TheracosBio's tech stack includes WordPress, jQuery Migrate, Nginx, Astra, Yoast SEO.

Pharmaceutical ManufacturingUnited States2-10 Employees

TheracosBio is a pharmaceutical company located in Framingham, Massachusetts. TheracosBio discovers, develops and commercializes medicines for important diseases. TheracosBio believes that affordable medications for prevalent conditions may lead to more rapid advances in public health.

TheracosBio has gained FDA approval of its proprietary medicine Brenzavvy™ (bexagliflozin). Press release: https://bit.ly/3HtSZ6y